OnDemand Innovation Webinar:

 Immune Tolerance in Transplantation : The Holy Grail or an Attainable Goal? -


Presented on Thursday, April 5, 2018
Continuing education credits available until:
Thursday, April 4, 2019

Gerald Brandacher, MD - Speaker
Scientific Director, Composite Tissue Allotransplantation Program

Associate Professor of Plastic & Reconstructive Surgery
Johns Hopkins Hospitals
Baltimore, MD

Click here for speaker biography.

Purpose /Goal:
Immunosuppressants are crucial to minimize the risk of rejection of an organ transplant, however, these agents have a host of additional undesired risks, toxicities, and side-effects. Studies in the field of tolerance induction, wherein bone marrow from the donor is utilized in conjunction with the organ transplant, are progressing with promising results in kidney recipients. Several other strategies using cell-based immunomodulation are currently developed in other organ systems including VCA. During this webinar, we will learn the physiology of tolerance induction therapies, their indication and recommended protocols.
Target Audience:
Members of the donation and transplantation community serving diverse populations to include administrators, coordinators, physicians, nurses, surgeons, managers, quality improvement specialists, social workers, and other donation and transplantation center professionals and their colleagues.
Learning Objectives:
At the end of the webinar, participants should be able to:
  • Explain the physiology and immunological mechanisms of tolerance induction
  • Describe the process for bone marrow and other cell based immunomodulatory protocols..
  • Review the outcomes of current ongoing tolerance trials and experimental protocols.
  • Discuss the risks and benefits of tolerance induction
Click here for more details on continuing education credits.




OnDemand Recording - Available Until 4/4/19: Immune Tolerance in Transplantation : The Holy Grail or an Attainable Goal

Register Now

  • Thursday Apr 04 2019, 2:00 PM - 3:00 PM